Skip to main content
. 2021 Sep 27;12:730320. doi: 10.3389/fimmu.2021.730320

Figure 2.

Figure 2

Forest plot (random-effects model) of the association between ICI rechallenge and all-grade or high-grade irAE occurrence after ICI rechallenge. CI, confidence interval; ICIs, immune checkpoint inhibitors; irAEs, immune-related adverse events; M-H, Mantel–Haenszel model. The sizes of the squares indicate the weight of the study. High-grade was considered as grade ≥3.